Centrex CEO Named to Board of Directors of the Bio-Defense Research Group.Business Editors/Health/Medical Writers TULSA, Okla.--(BUSINESS WIRE)--Sept. 2, 2003 Centrex, Inc. (OTCBB OTCBB See OTC Bulletin Board (OTCBB). :CNEX) and Bio-Defense Research Group, Inc. (BDRGI) today announced that they have entered into a strategic alliance to explore the joint applications, development and marketing of their complimentary technologies. Under the terms of the alliance, both companies will focus on their individual areas of expertise while investigating potential collaborations that would serve to deliver to the marketplace complete biological detection and filtering systems. Centrex CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. Thomas R. Coughlin, Jr., M.D. has been named to the Board of Directors of BDRI in conjunction with the agreement. BDRGI CEO, Preston D. McGee, Sr., Pd.D. has likewise been named to the Board of Centrex. Bio-Defense Research Group, Inc. of Upper Marlboro, Maryland Greater Upper Marlboro, Maryland Upper Marlboro is a town in Prince George's County, Maryland, United States. The live-in population of the town core proper was only 648 at the 2000 census, although Greater Upper Marlboro is many times larger. , is a privately held biomedical technology corporation that provides HVAC (Heating Ventilation Air Conditioning) In the home or small office with a handful of computers, HVAC is more for human comfort than the machines. In large datacenters, a humidity-free room with a steady, cool temperature is essential for the trouble-free (Heating-Ventilation-Air Conditioning) solutions for commercial, government, military, educational, airline and transportation applications. The system, which destroys airborne biological agents as they move through heating and air conditioning ducts, was developed by The Johns Hopkins University Johns Hopkins University, mainly at Baltimore, Md. Johns Hopkins in 1867 had a group of his associates incorporated as the trustees of a university and a hospital, endowing each with $3.5 million. Daniel C. Applied Physics Laboratory The Johns Hopkins University Applied Physics Laboratory (APL), located in Laurel, Maryland, is a not-for-profit, university-affiliated research center employing 4,000 people. , Laurel, Md., and has been exclusively licensed to BDRGI, for production. BDRGI's novel product, Path-Away(R), is a one of a kind proprietary technology that sets the standard for HVAC pathogen neutralization neutralization, chemical reaction, according to the Arrhenius theory of acids and bases, in which a water solution of acid is mixed with a water solution of base to form a salt and water; this reaction is complete only if the resulting solution has neither acidic nor and destruction. BDRGI is developing a group of innovative products that will serve to accelerate the discovery and destruction of airborne pathogens. BDRGI's strengths include expertise in the fields of Biophysics biophysics, application of various methods and principles of physical science to the study of biological problems. In physiological biophysics physical mechanisms have been used to explain such biological processes as the transmission of nerve impulses, the muscle , Occupational Health, Mechanical and Structural Engineering, Emergency Medicine, and Molecular Biology. For more information, visit www.BDRGI.com. "We are extremely excited about the new strategic relationship between Centrex and BDRGI and believe that it positions both companies to offer the best in new technologies that will work together to combat the threat of exposure to biological agents," said Centrex CEO, Thomas R. Coughlin, Jr. About Centrex, Inc. Centrex owns the exclusive worldwide license to develop, manufacture and market a system for detecting microbial microbial pertaining to or emanating from a microbe. microbial digestion the breakdown of organic material, especially feedstuffs, by microbial organisms. contamination in air, food and water. The detection system is designed to be adaptable and easily tailored to detect a variety of bacterial and viral organisms by recognizing the unique DNA fingerprint of the organism. The proposed device is a simultaneous multi-channel detection system that is compact, fully automated and capable of monitoring the presence of biological agents in air, food and water. For further information, call Ron Wheet at: 843-971-4848 or visit the Company website: www.centrexcorporation.com. This press release contains some forward-looking statements. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Forward-looking statements in this document should be evaluated together with the many uncertainties that affect our business. Those uncertainties are discussed in the Company's SEC filings. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion